Eton Pharmaceuticals Inc

ETONNASDAQ · USD
56.47USD+0.97 (+1.75%)
6310

Eton Pharmaceuticals Inc (ETON) Covered Calls

Loading ETON covered call opportunities from the prior session (coming three months window)…

Read more

Running ETON covered calls helps you generate consistent income from Eton Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Eton Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best ETON covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if ETON stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling ETON covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Eton Pharmaceuticals Inc covered call is worth writing.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Income-focused investors, long-term ETON holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling ETON covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Eton Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile6.75% Subdued
  • Market cap (M$)1,586
  • 52 weeks high-16.38%
  • 52 weeks low288.93%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$71.00
    25.73% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E146.75
  • Future P/E26.43
  • EPS (ttm)0.38
  • EPS growth next 5 years107.40%

As of September 18, 2026

No illustrative rows to display.

As of September 18, 2026

Sell covered calls with the data behind you

Find the best ETON covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial